Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Condition: Plaque Psoriasis Interventions: Biological: Ixekizumab; Drug: Methotrexate; Drug: Cyclosporin A; Drug: Acitretin Sponsors: Singapore General Hospital; Translational Immunology Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 3, 2020 Category: Research Source Type: clinical trials